Codexis (CDXS) Interest Expenses (2010 - 2026)
Codexis' (CDXS) quarterly Interest Expenses came in at $40.5 million in Q1 2026, up 3250.41% year-on-year from $1.2 million in Q1 2025, and up 4362.29% quarter-over-quarter from $907000.0 in Q4 2025.
Codexis (CDXS) Interest Expenses (2010 - 2026) Analysis & Trends
Codexis' Interest Expenses history runs 17 years deep, the most recent figure standing at $40.5 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 3250.41% year-over-year to $40.5 million in Q1 2026; TTM through Mar 2026 was $40.5 million, a 821.31% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, down 96.6% from the prior year.
- Interest Expenses grew to $40.5 million in Q1 2026 per CDXS's latest filing, from $907000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $56.0 million in Q2 2022 and bottomed at -$5.6 million in Q4 2023.
- The 5-year median for Interest Expenses is $1.2 million (2025), against an average of $13.9 million.
- Biggest YoY gain for Interest Expenses was 56580.0% in 2023; the steepest drop was 186.74% in 2023.
- Year by year, Interest Expenses stood at $6.5 million in 2022, then slumped by 186.74% to -$5.6 million in 2023, then surged by 121.07% to $1.2 million in 2024, then slipped by 23.46% to $907000.0 in 2025, then surged by 4362.29% to $40.5 million in 2026.
- Per Business Quant, the three latest CDXS Interest Expenses figures stand at $40.5 million (Q1 2026), $907000.0 (Q4 2025), and $36.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | 40.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.47 Mn |
| Mar 31, 2026 | 40.47 Mn |
| Dec 31, 2025 | 907,000.00 |
| Dec 31, 2025 | 907,000.00 |
| Sep 30, 2025 | 36.75 Mn |
| Sep 30, 2025 | 36.75 Mn |
| Jun 30, 2025 | 37.97 Mn |
| Jun 30, 2025 | 37.97 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | -5.62 Mn |
| Dec 31, 2023 | -5.62 Mn |